Videos
  • Featured
  • Topics
  • Partners
  • Register
  • Login
Filters 123 Videos
Upload Date
  • Today
  • This Week
  • This Month
  • This Year
Category
  • Innovations
  • Research
  • Sites & Resources
  • Services
  • Thought Leaders
  • Events & Education
  • Advocacy
2017 Fast Lane Honoree Avery Therapeutics

AZBio

10/13/2017
2017 Fast Lane Honoree Avery Therapeutics

More than 26 million people worldwide suffer from heart failure and the number of cases is increasing at more than 13% per year. In the US, heart failure is the number one cause of hospital readmissions in patients over 65 and results in over $39 billion in treatment costs annually. The progression of heart failure results in a 50% mortality rate within 5 years of diagnosis. But what if it didn’t have to be like this? That is a question being addressed by the team at Avery Therapeutics, Inc. The startup company is based on the application of technology invented at the University of Arizona College of Medicine-Tucson and the Southern Arizona VA. In 2017, Avery Therapeutics licensed the beating heart graft technology from the University of Arizona. Pre-clinical studies have already shown that the technology, called MyCardia™, improves heart function.

AZBio PSA 1

AZBio

10/22/2015
AZBio PSA 1

Clinical Trials in Arizona

AZBio

05/11/2015
Clinical Trials in Arizona

Joan Koerber-Walker, President & CEO of AZBio provides a look at how Arizona stacks up when it comes to clinical trials.

Reshaping the Patient Experience (Panel)

AZBio

05/18/2016
Reshaping the Patient Experience (Panel)

Moderated by Jude LaCava, Co-founder, Dorothy Foundation; Panelists: -Eric Greenman, MD, Founder and Chief Medical Officer, iTel Companies; Marie Wesslehoft, President & Co-founder,   MSDx; Neel Mehta, Co-founder and Chief Strategy Officer,  EpiFinder Inc.



Bard Peripheral Vascular - 2017 Arizona Bioscience Company of the Year

AZBio

10/13/2017
Bard Peripheral Vascular - 2017 Arizona Bioscience Company of the Year

Bard Peripheral Vascular specializes in the development of surgical and interventional devices for the treatment of diseases affecting the peripheral vascular system, which consists of veins and arteries in the arms, hands, legs, and feet. The peripheral arteries supply oxygenated blood to the body, and the peripheral veins lead deoxygenated blood from the capillaries in the extremities back to the heart.

Clinical Trials in Arizona -  CBR

AZBio

05/16/2015
Clinical Trials in Arizona - CBR

Cord Blood Registry® (CBR®) is the world’s largest newborn stem cell company. Founded in 1992, CBR is entrusted by parents with storing samples from more than 500,000 children. CBR is dedicated to advancing the clinical application of cord blood and cord tissue stem cells by partnering with institutions to establish FDA-regulated clinical trials for conditions that have no cure today  Presenter: CeciliaFairley, Clincial Specialist at Cord Blood Registry

2014 Arizona Bioscience Educator of the Year Miles Orchinik

AZBio

10/04/2014
2014 Arizona Bioscience Educator of the Year Miles Orchinik

2014 Arizona Bioscience Researcher of the Year Charles Arntzen PhD

AZBio

10/04/2014
2014 Arizona Bioscience Researcher of the Year Charles Arntzen PhD

Telemedicine, a Global View

AZBio

05/18/2016
Telemedicine, a Global View

Roger Downey, GlobalMed



Arizona's Bioindustry is Blooming

AZBio

10/13/2017
Arizona's Bioindustry is Blooming

Photos Courtesy of : ASU Biodesign Institute, Banner Health, Barrow Neurological Institute, Northern Arizona University, TGen, The University of Arizona, UA College of Medicine Phoenix. All rights reserved

  • << First
  • < Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next >
  • Last >>

Privacy Statement

ON-LINE PRIVACY PRACTICES

Privacy Statement..

Legal Notes

ON-LINE LEGAL PRACTICES

Legal Notes…

Links

  • What is AZBio.tv?
  • Customer Support
  • Become an Advertiser

Media Contact

480-779-8101

AdvancingBio@AZbio.org

Follow Us On

  • Home
  • Privacy
  • Legal Notes

© Copyright 2023 Arizona BioIndustry Association | 480-779-8101

Powered By New Angle Media